PHARMACY

Hikma is offering clobazam oral suspension and clobazam tablets, which had a market value of $260 million and $601 million respectively.

The FDA's revised draft guidance aims to protect patients from contaminated or substandard compounded drugs.

Xospata's approval marks the first FLT3-targeting therapy for acute myeloid leukemia.

DSN has named Albertsons its 2018 Pharmacy Innovator of the Year for the chain's longtime focus on patient care that it empowers its pharmacists to provide.

The Food and Drug Administration and World Health Organization are launching a pilot called the Collaborative Registration Procedure-Lite to expedite HIV drug applications.

As it grows its specialty operation, Albertsons has focused on offering patients the option of picking up their prescriptions at their local store to build a more personalized approached.

As health care spending growth slowed to 3.9%, retail prescription drug spending growth fell to 0.4% — the lowest it's been since 2012, according to a report from the Centers for Medicare and Medicaid services.

Catalyst's Firdapse provides a treatment for Lambert-Eaton myasthenic syndrome — a rare autoimmune disorder.